Document is current
Any future updates will be listed below
-
Authors
Jonas, Jost B.
Yan, Yan Ni
Zhang, Qi
Jonas, Rahul A.
Wang, Ya Xing
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (#81570835)
- License Information
-
More Information
Article History
Received: 14 April 2021
Accepted: 5 July 2021
First Online: 19 July 2021
Competing interests
: Financial Disclosures:Jost B. Jonas and Rahul A. Jonas: European patent application 16 720 043.5 and US patent application US 2019 0085065 A1: „Agents for use in the therapeutic or prophylactic treatment of myopia or hyperopia). Jost B. Jonas: Advisory Board Novartis; Patent holder with Biocompatibles UK Ltd. (Farnham, Surrey, UK) (Title: Treatment of eye diseases using encapsulated cells encoding and secreting neuroprotective factor and /or anti-angiogenic factor; Patent number: 20120263794), Patent application: Agents for the use in the therapeutic or prophylactic treatment of retinal pigment epithelium associated diseases. All other authors: No financial disclosures.
